María Pilar Alzuguren Maza-rekin lankidetzan egindako argitalpenak (8)

2012

  1. AAV vectors transduce hepatocytes in vivo as efficiently in cirrhotic as in healthy rat livers

    Gene Therapy, Vol. 19, Núm. 4, pp. 411-417

2011

  1. Self-inactivating helper virus for the production of high-capacity adenoviral vectors

    Gene Therapy, Vol. 18, Núm. 11, pp. 1025-1033

2009

  1. Evaluation of bioluminescent imaging for noninvasive monitoring of colorectal cancer progression in the liver and its response to immunogene therapy

    Molecular Cancer, Vol. 8

2008

  1. Lethality in an anti-angiogenic tumor gene therapy model upon constitutive but not inducible expression of the soluble vascular endothelial growth factor receptor 1

    Journal of Gene Medicine, Vol. 10, Núm. 10, pp. 1083-1091

2007

  1. Human adenovirus replicates in immunocompetent models of pancreatic cancer in Syrian hamsters

    Human Gene Therapy, Vol. 18, Núm. 8, pp. 681-690

2006

  1. Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector

    Cancer Research, Vol. 66, Núm. 3, pp. 1620-1629

2003

  1. Protection against liver damage by cardiotrophin-1: A hepatocyte survival factor up-regulated in the regenerating liver in rats

    Gastroenterology, Vol. 125, Núm. 1, pp. 192-201

2000

  1. Liver damage using suicide genes: A model for oval cell activation

    American Journal of Pathology, Vol. 157, Núm. 2, pp. 549-559